MNKD (STOCKS)
Mannkind Corporation
$2.640000
+0.070000 (+2.72%)
Prev close: $2.570000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Michael E. Castagna
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $810.30M
- Employees
- 407
- P/E (TTM)
- 137.43
- P/B (TTM)
- -15.93
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
8
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.05 | $0.01 | -0.0647 | -440.14% |
|
Sep 2025 (Q3)
|
$0.07 | $0.02 | +0.0451 | +205.94% |
|
Jun 2025 (Q2)
|
$0.00 | $0.05 | -0.0481 | -100.00% |
|
Mar 2025 (Q1)
|
$0.04 | $0.04 | -0.0049 | -10.91% |
Financial Statements
| Revenues | $348.97M |
| Benefits Costs and Expenses | $347.56M |
| Cost Of Revenue | $26.80M |
| Costs And Expenses | $310.17M |
| Gross Profit | $322.17M |
| Nonoperating Income/Loss | -$37.39M |
| Operating Expenses | $87.96M |
| Selling, General, and Administrative Expenses | $144.14M |
| Depreciation and Amortization | $12.28M |
| Operating Income/Loss | $38.80M |
| Income/Loss From Continuing Operations After Tax | $5.86M |
| Income/Loss From Continuing Operations Before Tax | $1.41M |
| Income Tax Expense/Benefit | -$4.46M |
| Income Tax Expense/Benefit, Current | $493.00K |
| Income Tax Expense/Benefit, Deferred | -$19.47M |
| Interest Expense, Operating | $9.54M |
| Net Income/Loss | $5.86M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $5.86M |
| Net Income/Loss Available To Common Stockholders, Basic | $5.86M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.02 |
| Diluted Earnings Per Share | $0.02 |
| Basic Average Shares | 305,639,000 |
| Diluted Average Shares | 314,112,000 |
| Assets | $792.18M |
| Current Assets | $291.58M |
| Inventory | $35.31M |
| Other Current Assets | $256.27M |
| Noncurrent Assets | $500.60M |
| Fixed Assets | $82.42M |
| Intangible Assets | $5.07M |
| Other Non-current Assets | $413.11M |
| Liabilities | $843.20M |
| Current Liabilities | $171.03M |
| Accounts Payable | $9.03M |
| Wages | $27.65M |
| Other Current Liabilities | $134.35M |
| Noncurrent Liabilities | $672.17M |
| Long-term Debt | $354.64M |
| Other Non-current Liabilities | $317.53M |
| Equity | -$51.02M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$51.02M |
| Liabilities And Equity | $792.18M |
| Net Cash Flow From Operating Activities | $18.26M |
| Net Cash Flow From Operating Activities, Continuing | $18.26M |
| Net Cash Flow From Investing Activities | -$304.80M |
| Net Cash Flow From Investing Activities, Continuing | -$304.80M |
| Net Cash Flow From Financing Activities | $315.10M |
| Net Cash Flow From Financing Activities, Continuing | $315.10M |
| Net Cash Flow | $28.55M |
| Net Cash Flow, Continuing | $28.55M |
| Comprehensive Income/Loss | $4.87M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $4.87M |
| Other Comprehensive Income/Loss | -$994.00K |